Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability score
Mathilde Labouret,Vincent Trebossen,Alexandra Ntorkou,Sophie Bartoli,Mélodie Aubart,Stéphane Auvin,Brigitte Bader-Meunier,Véronique Baudouin,Olivier Corseri,Glory Dingulu,Camille Ducrocq,Cécile Dumaine,Monique Elmaleh,Nicole Fabien,Albert Faye,Isabelle Hau,Véronique Hentgen,Théresa Kwon,Ulrich Meinzer,Naim Ouldali,Cyrielle Parmentier,Marie Pouletty,Florence Renaldo,Isabelle Savioz,Jean-François Benoist,Enora Le Roux,Pierre Ellul,Isabelle Melki
DOI: https://doi.org/10.1177/09612033241229022
IF: 2.858
2024-02-07
Lupus
Abstract:Lupus, Ahead of Print. ObjectiveJuvenile systemic lupus erythematosus (j-SLE) is a rare chronic auto-immune disease involving several organs. Neuropsychiatric (NP) SLE (NPSLE) is frequent in j-SLE and associated with increased morbidity/mortality. Although NPSLE classification criteria exist, attributing NP features to j-SLE remains a major challenge. The study objective is to thoroughly describe j-NPSLE patients and assist in their diagnosis.MethodsThis is a 4-year retrospective monocentric study of j-SLE patients. NP events were attributed to j-SLE using standardised diagnostic criteria and multidisciplinary paediatric clinical expertise. Clinical features, brain magnetic resonance imaging (MRI)s and samples analysis including cerebrospinal fluid were assessed. A risk of j-NPSLE score was developed based on multivariable logistic regression analysis.ResultsOf 39 patients included, 44% were identified as having j-NPSLE. J-NPSLE diagnosis was established at the onset of j-SLE in 59% of patients. In addition to frequent kidney involvement (76%) and chilblains (65%), all j-NPSLE patients displayed psychiatric features: cognitive symptoms (82%), hallucinations (76%), depressed mood (35%), acute confused state (18%) and catatonia (12%). Neurological involvement was often mild and nonspecific, with headache (53%) in about half of the patients. The main features reported on brain MRI were nonspecific T2/FLAIR white matter hyperintensities (65%), and cerebral atrophy (88%). Upon immunosuppressive treatment, clinical improvement of NP features was observed in all j-NPSLE patients. The score developed to attribute j-NPSLE probability, guide further investigations and appropriate treatments is based on hallucinations, memory, sleep and renal involvement (Sensitivity: 0.95 Specificity: 0.85). Cerebrospinal fluid (CSF) neopterin assessment increases the score sensitivity and specificity.ConclusionPhysicians should carefully and systematically assess the presence of NP features at diagnosis and early stages of j-SLE. For j-NPSLE patients with predominant psychiatric features, a multidisciplinary collaboration, including psychiatrists, is essential for the diagnosis, management and follow-up.
rheumatology